The Stockholm Stock Exchange ended Wednesday's trading session virtually unchanged ahead of the evening's interest rate decision from the Federal Reserve, where a 25 basis point cut is anticipated. Developments on Europe's leading stock markets mirrored those in Stockholm.
At the close, the OMXS30 index was up 0.07 percent at 2,810.59. Shares worth approximately SEK 18.2 billion were traded on the Stockholm Exchange.
The real estate sector led among the market's major industrial groups, rising 0.9 percent. On the other end, telecoms lagged behind, down 0.9 percent.
Among the leading stocks included in the OMXS30 index, Boliden climbed 2.1 percent, while Investor A rose 1.8 percent. The weakest performers were Evolution, down 1.4 percent, and Ericsson B, which fell 1.3 percent.
Forest and garden products company Husqvarna unveiled new financial and sustainability targets through 2030. The company is driving a transformation toward profitable growth by focusing its portfolio, increasing efficiency, and investing in innovation, particularly in robotics and irrigation. The group is targeting organic growth of 3–5 percent, an operating margin above 10 percent, and a return on capital employed of 15 percent over an economic cycle. The dividend policy of distributing 40 percent of profits remains unchanged. The stock dropped 1.2 percent.
Investment company Investor saw a minor rally ahead of Wall Street's opening. The share climbed just over 3 percent on the Stockholm Exchange at its peak before retreating slightly. At its intraday high, Investor's market capitalization briefly surpassed SEK 1 trillion--a new milestone for the company. At the close, the stock was up 1.8 percent.
DIY retailer Clas Ohlson reported an operating profit of SEK 410 million for the second quarter of its broken fiscal year, August to October 2025, in line with analyst expectations. November sales rose by 3 percent, and the holiday shopping season has started well for the company. The stock, however, fell 15.8 percent.
Delistings from the Swedish market continue. Amplex has now made a bid for medical technology company Addvise Group worth approximately SEK 1 billion. Amplex is offering SEK 1.65 per share and SEK 0.49 per warrant in cash, valuing Addvise at around SEK 1.05 billion. The premium is 41.5 percent over yesterday's closing price. However, A shares have a negative premium of 17.3 percent compared to yesterday's close. The stock surged 28.3 percent.
Technology trading company Addtech's Automation business area has signed an agreement to acquire 80 percent of the shares in Cubro, a European supplier of monitoring, security, and analytics solutions for data networks headquartered in Vienna, with sales of approximately EUR 15 million. The stock was down 0.2 percent.
Real estate company Platzer has decided to repurchase up to SEK 100 million of its B shares to adjust its capital structure, thereby creating increased value for shareholders and enabling share delivery within the company's incentive program. The stock rose 2.7 percent.
Data storage company Proact will incur one-off costs of about SEK 55 million in the fourth quarter related to the completion of the cost-efficiency program initiated earlier this year. These costs are mainly attributable to staff reductions and management changes within Business Unit Central, Business Unit West, and group functions. The stock increased 0.6 percent.
Pharmaceutical development company Egetis Therapeutics, through its subsidiary, has entered into an expanded exclusive distribution agreement with Turkey's Er-Kim to supply Emcitate for the treatment of MCT8 deficiency in several European countries. The stock rose 2.6 percent.
Eyetracking company Tobii's board has appointed Fadi Pharaon as the new CEO, effective January 1, 2026. Pharaon has worked for over 25 years at Ericsson, holding several senior positions and serving on the company's executive management team. The stock jumped 5 percent.
On the analysis front, Aktiespararna issued a buy recommendation for FM Mattsson, which rose 7.4 percent.
ABG Sundal Collier has initiated coverage of Bravida with a buy rating and a target price of SEK 110. The stock increased 1.4 percent.
